Literature DB >> 35984488

Primary effusion anaplastic large cell lymphoma with indolent clinical course and IRF4/DUSP22 rearrangement: a case report expanding the spectrum of effusion-based lymphoma.

Chang-Tsu Yuan1,2,3, Ann-Lii Cheng4, Hsin-An Hou5.   

Abstract

Effusion-based lymphomas arising from pleural cavities are mostly B cell lymphomas. Non-B cell origins are very rare. These non-B cell lymphomas are usually disseminated and aggressive, and their underlying genetic changes are indeterminate. Here, we reported the first case of primary effusion anaplastic large cell lymphoma (ALCL) with exclusive involvement of a single body cavity, indolent initial presentation, and IRF4/DUSP22 rearrangement. This 73-year-old man had been in his usual health until he presented with exertional dyspnea for 1 month. Physical examination and whole-body imaging indicated isolated left pleural effusion without lymphadenopathies or tumors. Thoracentesis revealed anaplastic large lymphoid cells that were CD30 + , CD3 - , CD8 + , TIA1 + , CD138 - , Epstein-Barr virus-encoded small RNA - , human herpesvirus 8 - , and ALK - . Fluorescence in situ hybridization exhibited IRF4/DUSP22 rearrangement. A primary effusion ALK-negative ALCL was diagnosed. There was no evident progression without chemotherapeutics until 4 months after the diagnosis. Our findings expanded the spectrum of effusion-based lymphoma. Recognition of this disease could prevent misdiagnosis and guide treatment strategies for patients.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  ALK; Anaplastic large cell lymphoma; Effusion-based lymphoma; HHV8; IRF4/DUSP22; Primary effusion lymphoma

Year:  2022        PMID: 35984488     DOI: 10.1007/s00428-022-03385-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.535


  11 in total

1.  Genetic subtyping of breast implant-associated anaplastic large cell lymphoma.

Authors:  Naoki Oishi; Garry S Brody; Rhett P Ketterling; David S Viswanatha; Rong He; Surendra Dasari; Ming Mai; Hailey K Benson; Christopher A Sattler; Rebecca L Boddicker; Ellen D McPhail; N Nora Bennani; Christin A Harless; Kuldeep Singh; Mark W Clemens; L Jeffrey Medeiros; Roberto N Miranda; Andrew L Feldman
Journal:  Blood       Date:  2018-06-19       Impact factor: 22.113

Review 2.  Primary effusion anaplastic large cell lymphoma in a patient with long-standing dermatitis herpetiformis and celiac disease.

Authors:  Mehdi Nassiri; Michael J Robertson; Lawrence Hertzberg; Magdalena B Czader
Journal:  Ann Hematol       Date:  2012-08-23       Impact factor: 3.673

3.  Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma.

Authors:  Aishwarya Ravindran; Andrew L Feldman; Rhett P Ketterling; Surendra Dasari; Karen L Rech; Ellen D McPhail; Paul J Kurtin; Min Shi
Journal:  Am J Surg Pathol       Date:  2021-04-01       Impact factor: 6.394

4.  Primary effusion lymphoma in Taiwan shows two distinctive clinicopathological subtypes with rare human immunodeficiency virus association.

Authors:  Bo-Jung Chen; Ran-Ching Wang; Chung-Han Ho; Chang-Tsu Yuan; Wan-Ting Huang; Sheau-Fang Yang; Pin-Pen Hsieh; Yun-Chih Yung; Shih-Yao Lin; Chen-Fang Hsu; Ying-Zhen Su; Chun-Chi Kuo; Shih-Sung Chuang
Journal:  Histopathology       Date:  2018-02-14       Impact factor: 5.087

5.  Lymphadenopathy Associated With Neutralizing Anti-interferon-gamma Autoantibodies Could Have Monoclonal T-cell Proliferation Indistinguishable From Malignant Lymphoma and Treatable by Antibiotics: A Clinicopathologic Study.

Authors:  Chang-Tsu Yuan; Jann-Tay Wang; Wang-Huei Sheng; Pei-Yuan Cheng; Chein-Jun Kao; Jann-Yuan Wang; Chien-Yuan Chen; Jau-Yu Liau; Jia-Huei Tsai; Yi-Jyun Lin; Chung-Chung Chen; Yee-Chun Chen; Shan-Chwen Chang; Un-In Wu
Journal:  Am J Surg Pathol       Date:  2021-05-20       Impact factor: 6.394

6.  Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.

Authors:  C Laurent; A Delas; P Gaulard; C Haioun; A Moreau; L Xerri; A Traverse-Glehen; T Rousset; I Quintin-Roue; T Petrella; J F Emile; N Amara; P Rochaix; M P Chenard-Neu; A M Tasei; E Menet; H Chomarat; V Costes; L Andrac-Meyer; J F Michiels; C Chassagne-Clement; L de Leval; P Brousset; G Delsol; L Lamant
Journal:  Ann Oncol       Date:  2015-11-23       Impact factor: 32.976

Review 7.  Anaplastic Large Cell Lymphoma Manifesting as Pleural Effusion in a Patient with Long-Standing Eosinophilia.

Authors:  Chethan K Belludi; Edward T Qian; James J Tolle; Ryan M Brown; Mary Ann Thompson; Ridas Juskevicius
Journal:  Lab Med       Date:  2019-01-01

Review 8.  Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis.

Authors:  Rebecca L King; John R Goodlad; Maria Calaminici; Snjezana Dotlic; Santiago Montes-Moreno; Ilske Oschlies; Maurilio Ponzoni; Alexandra Traverse-Glehen; German Ott; Judith A Ferry
Journal:  Virchows Arch       Date:  2019-12-20       Impact factor: 4.064

9.  Anaplastic large cell lymphoma presenting as a pleural effusion and mimicking primary effusion lymphoma. A report of 2 cases.

Authors:  Alexander Chak-Lam Chan; John Kwok-Cheung Chan; Kin Wing Yan; Yok Lam Kwong
Journal:  Acta Cytol       Date:  2003 Sep-Oct       Impact factor: 2.319

10.  An effusion-based presentation of ALK- anaplastic large cell lymphoma.

Authors:  Yue Zhao; Endi Wang
Journal:  Blood       Date:  2021-05-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.